MARKETSStocks End Lower and Wall Street Posts a Miserable First QuarterBy Joseph Woelfel18 minutes ago
MARKETSWall Street Rallies, Coronavirus Deaths Soar in New York, Gap Furloughs Workers - 5 Things You Must Know TuesdayBy Joseph Woelfel9 hours ago
MARKETSDow Ends Nearly 700 Points, or 3.2%, Higher With Johnson & Johnson Leading GainsBy Joseph WoelfelMar 30, 2020 4:19 PM EDT
INVESTINGHow to Trade Abbott Labs After FDA Approves Coronavirus TestBy Richard SuttmeierMar 30, 2020 2:10 PM EDT
HEALTHCoronavirus Latest Updates: A Timeline of Recent EventsBy Steve FiorilloMar 30, 2020 12:05 PM EDT
INVESTINGAbbott Labs Shares Surge After FDA Approves 'Five Minute' Coronavirus TestBy Martin BaccardaxMar 30, 2020 12:36 PM EDT
STOCKSAbbott's 5-Minute Coronavirus Test Gets Emergency Use Approval From FDABy Joseph WoelfelMar 28, 2020 11:51 AM EDT
PRESS RELEASESAbbott Launches Molecular Point-of-Care Test To Detect Novel Coronavirus In As Little As Five MinutesBy PR NewswireMar 27, 2020 7:20 PM EDT
EARNINGS2020 Earnings Calendar: When Do Top Companies Report This Quarter?By Steve FiorilloMar 26, 2020 1:12 PM EDT
JIM CRAMERFighting for the Economy: Cramer's 'Mad Money' Recap (Friday 3/20/20)By Scott RuttMar 20, 2020 8:31 PM EDT
PRESS RELEASESAbbott Hosts Conference Call For First-Quarter EarningsBy PR NewswireMar 19, 2020 9:00 AM EDT
INVESTINGAbbott Labs Gets FDA Emergency Nod for Coronavirus TestsBy M. Corey GoldmanMar 19, 2020 1:56 PM EDT
PRESS RELEASESAbbott Receives FDA Emergency Use Authorization And Launches Test To Detect Novel CoronavirusBy PR NewswireMar 18, 2020 6:00 PM EDT
PRESS RELEASESAbbott Aims To Optimize TAVI Implants With European Approval Of FlexNav™ Delivery System For The Company's Portico™ ValveBy PR NewswireMar 5, 2020 9:00 AM EST
JIM CRAMERRough Road Ahead: Cramer's 'Mad Money' Recap (Friday 2/28/20)By Scott RuttFeb 28, 2020 8:53 PM EST
PRESS RELEASESAbbott Declares 385th Consecutive Quarterly DividendBy PR NewswireFeb 21, 2020 10:57 AM EST
PRESS RELEASESNew Real-World Data Show That Abbott's FreeStyle Libre System Delivers Positive Health Outcomes For People With Type 1 And Type 2 DiabetesBy PR NewswireFeb 20, 2020 8:00 AM EST
PRESS RELEASESAbbott And Insulet Partner To Integrate Next-Generation Glucose Sensing And Automated Insulin Delivery Technologies For Seamless Diabetes CareBy PR NewswireFeb 19, 2020 6:30 AM EST
PRESS RELEASESAbbott Introduces Next-Generation Heart Rhythm Management Devices In Europe, Featuring State-of-the-Art Patient App And Bluetooth ConnectivityBy PR NewswireFeb 18, 2020 7:45 AM EST
PRESS RELEASESAbbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device DesignationBy PR NewswireFeb 4, 2020 9:00 AM EST
PRESS RELEASESAbbott Announces First-of-Its-Kind Trial To Assess New Therapy Option For People At Risk Of StrokeBy PR NewswireFeb 3, 2020 9:00 AM EST
